54 related articles for article (PubMed ID: 23588848)
1. NGX6 expression improves the sensitivity of tamoxifen-resistant MCF-7 cells through modulation of the Smad signaling pathway.
Zhao WJ; Wang K
Int J Oncol; 2013 Jun; 42(6):2060-8. PubMed ID: 23588848
[TBL] [Abstract][Full Text] [Related]
2. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
3. Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line.
Banz-Jansen C; Münchow B; Diedrich K; Finas D
Arch Gynecol Obstet; 2011 Dec; 284(6):1543-9. PubMed ID: 21448710
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
5. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
6. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells.
Wang L; Ma J; Li J; Li X; Zhang Q; Peng S; Peng C; Zhou M; Xiong W; Yang J; Zhou J; Fan S; Tan C; Yan Q; Shen S; Li G
J Cell Biochem; 2005 May; 95(1):64-73. PubMed ID: 15723283
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
8. Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.
Zhang L; Ren X; Cheng Y; Huber-Keener K; Liu X; Zhang Y; Yuan YS; Yang JW; Liu CG; Yang JM
Biochem Pharmacol; 2013 Sep; 86(6):726-33. PubMed ID: 23856293
[TBL] [Abstract][Full Text] [Related]
9. 1α,25-dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells.
Lundqvist J; Yde CW; Lykkesfeldt AE
Steroids; 2014 Jul; 85():30-5. PubMed ID: 24747771
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
11. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
12. STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells.
Yi EH; Lee CS; Lee JK; Lee YJ; Shin MK; Cho CH; Kang KW; Lee JW; Han W; Noh DY; Kim YN; Cho IH; Ye SK
Mol Cancer Res; 2013 Jan; 11(1):31-42. PubMed ID: 23074171
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells.
Tu SH; Chang CC; Chen CS; Tam KW; Wang YJ; Lee CH; Lin HW; Cheng TC; Huang CS; Chu JS; Shih NY; Chen LC; Leu SJ; Ho YS; Wu CH
Breast Cancer Res Treat; 2010 Jun; 121(3):539-53. PubMed ID: 19655245
[TBL] [Abstract][Full Text] [Related]
14. CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.
Tang MR; Wang YX; Guo S; Han SY; Wang D
Apoptosis; 2012 Sep; 17(9):927-37. PubMed ID: 22538441
[TBL] [Abstract][Full Text] [Related]
15. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
16. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.
Yde CW; Emdal KB; Guerra B; Lykkesfeldt AE
Breast Cancer Res Treat; 2012 Aug; 135(1):67-78. PubMed ID: 22527100
[TBL] [Abstract][Full Text] [Related]
17. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
Berstein LM; Yue W; Wang JP; Santen RJ
Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
[TBL] [Abstract][Full Text] [Related]
18. CK20 expression enhances the invasiveness of tamoxifen-resistant MCF-7 cells.
Min YS; Yi EH; Lee JK; Choi JW; Sim JH; Kang JS; Kim YN; Juhnn YS; Kim HR; Ye SK
Anticancer Res; 2012 Apr; 32(4):1221-8. PubMed ID: 22493352
[TBL] [Abstract][Full Text] [Related]
19. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.
Kim R; Tanabe K; Emi M; Uchida Y; Toge T
Cancer; 2005 May; 103(10):2199-207. PubMed ID: 15830342
[TBL] [Abstract][Full Text] [Related]
20. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]